No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 246.1x · 10Y median 197.6x · 60th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 20
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:06:11.103Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T14:06:11.103Z. Latest historical point 2022-11-14. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T14:06:11.103Z. Latest historical point 2022-03-31.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T14:06:11.103Z. Latest historical point 2022-11-14. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Envoy Medical, Inc. (COCH) stock was $0.66 as of Oct 6, 2026, 9:59 AM EDT, up 1.38% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -19.9% · 3-year avg -46.7%/yr · 5-year avg -41.7%/yr
Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss.
Medical - Devices · White Bear Lake, MN
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 9, 2026
34 days away
EPS Estimate
-0.07
Revenue Est.
$50000.00
Last Quarter Results
EPS
$-0.07
vs Estimate
$-0.08
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1COCH | $50.95M | $0.66 | +1.38% | -19.94% | -41.73% | N/A | N/A |
| 2INMB | $51.28M | $1.93 | -0.57% | -6.70% | -36.88% | N/A | vs COCH |
| 3EXOZ | $51.51M | $5.55 | +0.54% | -58.32% | N/A | N/A | vs COCH |
| 4BTMD | $51.61M | $1.17 | +4.46% | -62.24% | -35.12% | N/A | vs COCH |
| 5MBOT | $51.72M | $1.14 | +6.07% | -64.98% | -31.63% | -39.57% | vs COCH |
| 6CLNN | $49.00M | $3.83 | -1.92% | -62.62% | -51.16% | N/A | vs COCH |
forward FY estimate
N/A
$51000.00
vs Estimate
$50000.00
Consensus Rating
Based on 2 analysts
Average Price Target
$2.00
+203.0% upside
Low
$2.00
Current
$0.66
High
$2.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.08 | $-0.07 | $-0.06 | 1 |
| Quarter ending Dec 2026 | $-0.09 | $-0.07 | $-0.06 | 1 |
| Quarter ending Mar 2027 | $-0.08 | $-0.07 | $-0.05 | 1 |
| Quarter ending Jun 2027 | $-0.07 | $-0.06 | $-0.04 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.30 | $-0.29 | $-0.28 | 1 |
| FY 2027 | $-0.23 | $-0.22 | $-0.21 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $41818.00 | $50000.00 | $58181.00 | 1 |
| Quarter ending Dec 2026 | $41818.00 | $50000.00 | $58181.00 | 1 |
| Quarter ending Mar 2027 | $41818.00 | $50000.00 | $58181.00 | 1 |
| Quarter ending Jun 2027 | $41818.00 | $50000.00 | $58181.00 | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $97392.00 | $100000.00 | $102607.00 | 1 |
| FY 2027 | $97392.00 | $100000.00 | $102607.00 | 1 |
